Results 131 to 140 of about 2,211 (199)

Correction: Kurzbaum et al. Exploring <i>Psilocybe cubensis</i> Strains: Cultivation Techniques, Psychoactive Compounds, Genetics and Research Gaps. <i>J. Fungi</i> 2025, <i>11</i>, 99. [PDF]

J Fungi (Basel)
Kurzbaum E, Páleníček T, Sharchaton A, Azerrad S, Dekel Y.   +4 more
europepmc   +1 more source

Advancing treatment paradigms: the role of psilocybin in managing major depressive disorder. [PDF]

Ann Med Surg (Lond)
Rasheed S, Arif R, Raza AA, Samadi A.
europepmc   +1 more source

The Potential Role of Psilocybin in Traumatic Brain Injury Recovery: A Narrative Review. [PDF]

Brain Sci
Palmer C, Ferber AT, Greenwald BD.
europepmc   +1 more source

Pharmacokinetics of Psilocybin: A Systematic Review. [PDF]

Pharmaceutics
Meshkat S, Al-Shamali H, Perivolaris A, Tullu T, Zeifman RJ, Zhang Y, Burback L, Winkler O, Greenshaw A, Husain MI, C Reichelt A, Vermetten E, Jha MK, Jetly R, Loebenberg R, Bhat V.   +15 more
europepmc   +1 more source

Comprehensive analysis of 42 psilocybin-producing fungal strains reveals metabolite diversity and species-specific clusters. [PDF]

Sci Rep
Cohen J, Sulimani L, Procaccia S, Lerenthal Y, Milay L, Taran I, Shapira A, Meiri D.   +7 more
europepmc   +1 more source

Assessing the Potential Cardiovascular Risk of Microdosing the Psychedelic LSD in Mice. [PDF]

ACS Pharmacol Transl Sci
Effinger DP, Schalk SS, King JL, Wallingford JR, O'Connell CK, Calderon JR, Kopecky BJ, McCorvy JD, Thompson SM.   +8 more
europepmc   +1 more source

Psilocybin and Bipolar Depression: Promise and Prudence. [PDF]

CNS Drugs
Marques MG, Patarroyo-Rodriguez L, Singh B.   +2 more
europepmc   +1 more source

Psychedelic Drugs Rediscovered-In Silico Study of Potential Fetal Exposure to Analogues of Psychedelic Drugs During Pregnancy. [PDF]

Molecules
Sobańska AW, Sobański AM, Brzezińska E.   +2 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Elucidating the Phase I metabolism of psilocin in vitro

Archives of Toxicology
Psilocin is a well-studied controlled substance with potential psychotherapeutic applications. However, research gaps remain regarding its metabolism. Our objective was to elucidate a comprehensive Phase I metabolic profile of psilocin to support its forensic management and clinical development.
Ziteng Wang, Evelyn Mei Ling Goh, Hooi Yan Moy   +2 more
exaly   +4 more sources